Substitution screening
Find out which alternatives to a substance of concern carry hazards or restrictions of their own, market by market.
ProjectsSubstitution screening
- Marit Elgersma
- Ada Okonkwo
- Simon Laurent
| Plasticiser |  EU |  GB | US TSCA | Prop 65 |  Washington |
|---|---|---|---|---|---|
| DINP | Pass, Clear | Pass, Clear | Flag, Watch | Warn, Listed | Fail, Restricted |
| DIDP | Pass, Clear | Pass, Clear | Flag, Watch | Warn, Listed | Fail, Restricted |
| DPHP | Flag, Watch | Pass, Clear | Pass, Clear | Pass, Clear | Fail, Restricted |
| DEHT | Pass, Clear | Pass, Clear | Pass, Clear | Pass, Clear | Pass, Clear |
| DINCH | Pass, Clear | Pass, Clear | Pass, Clear | Pass, Clear | Pass, Clear |
| TXIB | Flag, Watch | Pass, Clear | Pass, Clear | Pass, Clear | Pass, Clear |
- Restricted
- Prop 65: Listed
- Watch
- Clear
TXIB European Union
Harmonised classification proposed
- Proposal
- Repr. 2 and ED HH 1
- Stage
- Consultation opened 27 April 2026
- Today
- No harmonised classification
Your expert signs off every verdict
You get the alternatives screen, the checks agreed before screening starts, and the source behind every verdict.
Approval
Illustrative projectMarit Elgersma
Status: ApprovedHead of Product Stewardship, after checking every alternative against all 5 sets of rules
EU REACH and CLP
GB REACH and CLP
US TSCA
California Proposition 65
Safer Products for Washington
Foresight does the research
Your team brings what only it knows, and your expert makes the call at each checkpoint.
Tasks
Status: In progressIllustrative project3 of 5 tasks done.
Share the candidates
Your team
Status: DoneDraft the checks
Foresight
Status: DoneAgree the checks
CheckpointStatus: ApprovedMarit Elgersma
Screen every alternative
Foresight
Status: In progressApprove the screen
CheckpointStatus: Not startedMarit Elgersma
Kept current once it’s approved
Monitoring watches the measures behind your verdicts. When one moves, Foresight rechecks the cells it affects, and your expert reviews the change.
Monitoring
Illustrative projectWatching 4 measures behind the verdicts
Harmonised classification proposal for TXIB
REACH substance evaluation of DPHP
- Status: To review
TSCA section 6 rule for DINP
EPA’s 2026 regulatory agenda moved the proposed rule from July to November 2026. Rechecked, still flagged.
TSCA section 6 rule for DIDP
What we need from you
Four things, shared at setup before the project starts.
Your substances
The substance you want to replace and the alternatives you’re considering, by name and CAS number. Without a shortlist, Foresight can suggest candidates that do the same job.
Your markets
Where the finished product is sold, down to the US states with their own chemical laws.
Your priorities
What matters most, such as a market that already restricts the substance or a customer asking for a change.
Your approver
The person who agrees the checks and approves the screen.
What teams ask about this project
How do you screen each alternative?
Foresight checks each candidate against every agreed measure where you sell, including group rules as well as named substances. Washington’s limit for vinyl flooring covers any ortho-phthalate, so DPHP fails there although no rule names it.
Why flag an alternative that passes every rule today?
Because a proposal open today can become a restriction after the new formulation launches. TXIB has no harmonised classification, but Norway has proposed classifying it for reproductive toxicity and as an endocrine disruptor. The screen shows where each proposal stands, so your team decides with it in view.
Where does the evidence come from?
From the measures themselves: the regulations, the official lists and the regulators’ own records of each process. Every verdict links to its source, so your team can check the wording directly.
Who checks the screen before we use it?
The person you name. They agree the checks before screening starts, and check the verdicts against their sources at the end. Nothing is final until they approve it. These checks reduce the risk of error without removing it.
What happens when a rule changes?
Foresight rechecks the cells it affects, such as when a classification opinion or a proposed rule moves. The screen your expert approved stays as it is until they accept the change.
What does it cost?
The price follows the screen’s size: how many candidates and markets it covers. You see it with the scope, before any screening starts.
More ways to understand your exposure
Each runs the same way, with your expert approving the result.
- Substance risk heatmapRegulatory pressure by substance and market.
- Global legislation registerApplicable legislation, mapped to your scope and sources.
- Portfolio impact assessmentThe products, formulations and markets a regulatory change reaches.
- PFAS portfolio reviewWhere PFAS sit in your products, under each definition that applies.
- Market entry requirementsThe registrations, notifications and labels a product needs before it sells in a new market.
- Sustainable procurement reviewSuppliers and materials reviewed against your requirements.
Bring a substance to replace to a demo
Tell us the alternatives you’re considering, if any, and the markets you sell in. You’ll see the scope and the price before any screening starts.
